Lifeward Ltd. effected a 1-for-12 reverse share split of its ordinary shares on February 24, 2026, reducing the number of outstanding shares. The reverse split was undertaken to meet The Nasdaq Capital Market's minimum $1.00 per ordinary share bid price requirement for maintaining its listing. Shareholders approved amendments to the company's Articles of Association on January 6, 2026, to allow for a reverse share split within a 1-for-2 to 1-for-12 range and an increase in authorized share capital. The Finance Committee of the Board approved the 1-for-12 ratio on January 30, 2026, and the amendments to the Articles reflecting the split and increased authorized capital on February 16, 2026. The number of issued and outstanding ordinary shares was reduced from 18,339,098 to approximately 1,528,098. The total number of authorized ordinary shares was increased from 75,000,000 to 100,000,000 following the reverse split. Outstanding warrants and stock options will be proportionately adjusted, including their exercise prices. No fractional shares were issued; fractions were rounded down to the nearest whole share. The company's ordinary shares began trading on a split-adjusted basis on Nasdaq under the existing symbol LFWD on February 24, 2026, with a new CUSIP number M8216Q309.